Rituximab therapy for steroid-dependent minimal change nephrotic syndrome

Pediatric Nephrology

Volumn 21, Issue 11, 2006, Pages 1698-1700

  Gilbert, Rodney D ^a   Hulse, Eleanor ^a   Rigden, Susan ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

B lymphocytes; Drug therapy; Minimal change; Nephrotic syndrome; Rituximab; Steroid sensitivity

Indexed keywords

AZATHIOPRINE; CD19 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFLAZACORT; IMMUNOGLOBULIN; LEVAMISOLE; METHYLPREDNISOLONE; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; VINCRISTINE;

ADOLESCENT; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MINIMAL CHANGE GLOMERULONEPHRITIS; PATHOGENESIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; INFANT; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PREDNISONE; STEROIDS;

EID: 33748704524     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0228-x     Document Type: Article

References (16)

1. Van den Berg J, Weening JJ (2004) Role of the immune system in the pathogenesis of the idiopathic nephrotic syndrome. Clin Sci 107:125-136
2. Grimbert P, Audard V, Valancuite A, Pawlak A, Lang P, Guellaën G, Sahali D (2005) Abnormal RNA processing and altered expression of serine-rich proteins in minimal-change nephrotic syndrome. Pediatr Res 57:133-137
3. Mansour H, Cheval L, Elalouf JM, Aude JC, Alyanakian MA, Mougenot B, Doucet A, Deschenes G (2005) T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney Int 67:2168-2177
4. Benz K, Dötsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794-797
5. Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M (2005) Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 20:1660-1663
6. Meyrier A (2005) Mechanisms of disease: Focal segmental glomerulosclerosis. Nature Clin Prac Nephrol 1:44-54
7. Garin EH, Laflam P, Chandler L (1998) Anti-interleukin-8 antibody abolishes effects of lipoid nephrosis cytokine. Pediatr Nephrol 12:381-385
8. Niemir ZI, Stein H, Ciechanowicz A, Olejniczak P, Dworacki G, Ritz E, Czekalski S, Waldherr R (2004) The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. Am J Kidney Dis 43:983-998
9. Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242-247
10. Kemper MJ, Zepf K, Klaasen I, Link A, Muller-Wiefel DE (2005) Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse. Am J Nephrol 25:132-137
11. Koskimies O, Vilska J, Rapola J, Hallman N (1982) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544-548
12. Tarshish P, Tobin JN, Bernstein J, Edelmann CMJ (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769-776
13. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux M-F, Landais P, Lesavre P, Chaveau D, Knebelmann B, Broyer M, Grunfeld J-P, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: From childhood to adulthood. Am J Kidney Dis 41:550-557
14. Ruth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ (2005) Children with steroid-sensitive nephrotic syndrome come of age: Long-term outcome. J Pediatr 147:202-207
15. Hodson EM, Craig JC, Willis NS (2005) Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1523-1530
16. Marks SD, Tullus K (2006) Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus. Pediatr Nephrol 21:598-599